Navigation Links
Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
Date:4/15/2011

therapy to market."

Study Findings

The findings involve an analysis of 55 lipodystrophy patients who received metreleptin treatment – the largest lipodystrophy cohort reported to date. At baseline, 75 percent of patients had diabetes and were not achieving adequate glycemic control (A1C greater than or equal to 7 percent), and 75 percent of patients had hypertriglyceridemia (triglycerides greater than or equal to 200 mg/dL). Metreleptin treatment resulted in robust reductions from baseline in both measures, an effect that was evident within four months post treatment initiation and sustained for up to several years of treatment. In patients with diabetes, mean A1C decreased from 9.4 percent at baseline to under 7.0 percent at year three; in patients with hypertriglyceridemia at baseline, median triglyceride concentrations decreased from 500 mg/dL at baseline to under 200 mg/dL at year three.

Adverse events were generally consistent with known co-morbid conditions of lipodystrophy (pancreatitis, proteinuria, autoimmune/chronic hepatitis) or expected pharmacological effects of metreleptin (weight loss or insulin-induced hypoglycemia in the setting of improved insulin sensitivity in patients on high doses of insulin).

About Lipodystrophy

Lipodystrophy syndromes are characterized by abnormalities in adipose (fat) tissue distribution. Because patients with lipodystrophy do not have enough fat tissue, they typically also have a deficiency of leptin, a hormone secreted by fat cells that plays a key role in regulating metabolism. Beginning typically in childhood or adolescence, patients affected by lipodystrophy experience a loss of subcutaneous fat, which can result in multiple, often severe metabolic abnormalities, including extreme insulin resistance, very high triglyceride levels, difficult-to-control diabetes and hepatic steatosis (excess fat accumulation in the liver). These abnormalities put patients at a high r
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Mass. , Aug. 27, 2014  Decision ... different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology ... clinical trials that a biosimilar has been assessed ... biosimilar product they choose to prescribe. ... Service report entitled Acceptance of Biosimilars ...
(Date:8/27/2014)... 27, 2014   Los Angeles orthodontics expert, ... to patients who want to make their treatment even ... the OrthoSpaceship, all patients have a powerful tool to ... can be used by most patients with all types ... by using the AcceleDent® Aura system for a few ...
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
Breaking Medicine Technology:Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
... 20, 2011 Chembio Diagnostics, Inc. (OTC/QB: CEMI & ... diagnostic tests, announced today that the Company will release ... the open of the market on Thursday, November 3, ... be available immediately after 9:15 a.m. on our web ...
... Cardica, Inc. (Nasdaq: CRDC ) today announced that it ... 30, 2011, on Thursday, October 27, 2011, after the markets close. ... Time to discuss the financial results and provide an update on ... To access the live conference call on October 27, ...
Cached Medicine Technology:Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results 2Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results 3Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011 2
(Date:8/27/2014)... The American Brain Tumor Association is ... Research Fellowships and 2014-2015 Discovery Grant Awards. Through the ... the field with talented, bright young investigators who have ... effects, diagnosis and treatment of brain tumors. This year’s ... the potential to advance the understanding and treatment of ...
(Date:8/27/2014)... to help regulate the blood,s iron supply shows promise as ... results from the first human study of the ... the Journal of the American Society of Hematology ... cells are in short supply or do not function properly. ... enough oxygen, since there are fewer red blood cells to ...
(Date:8/27/2014)... trial participation in the largest ongoing observational study of ... representative of the larger patient base, according to a ... Udell. The study authors call into question the general ... suggest the use of broader enrollment criteria and existing ... that clinical trials can be tremendously expensive and a ...
(Date:8/27/2014)... University,s Center for Leadership in Disability (CLD) has ... and Child Health Bureau of the Health Resources ... Autism Plan for Georgia, aimed at improving services ... , In preparing for this project, CLD worked ... stakeholders from across Georgia. The resulting plan addresses ...
(Date:8/27/2014)... August 27, 2014 Jaha was founded with ... Jaha invested in creating the industry’s most affordable fitness tracker ... that no other apps possess. Jaha plans to ... differentiates in three simple steps: locate, challenge and motivate. ... Aug 26, 2014 to garner support and to raise awareness ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Drug represents first potential treatment for common anemia 2Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2
... study has shown that children, who are exposed to smoke, ... are likely to have impaired vitamin C levels. Earlier studies ... study, which involved 520 children aged 2 to 12 years, ... have plasma ascorbate concentrations that were lower by an average ...
... the recent past have argued about the implications of Hormone ... menopausal symptoms. A new study, however, has gone further to ... risk of developing breast cancer// if they consumed alcoholic beverages. ... alcohol consumption pattern and on whether they were on HRT ...
... immediately prior to menopause beginning with normal, biological, and ... menstrual periods, is a time of increased vulnerability to ... disorders. Earlier studies have shown that women who experienced ... two to three times more likely to have had ...
... A recent study called 'HERS' conducted by researchers of the ... women, has found that Hormone Replacement Therapy (HRT) may be ... go on to develop diabetes as well. ,The study ... did not or had "impaired fasting glucose" - a ...
... is almost an established truth now. However, many of us ... of pizza could do to our overall health. A recent ... //for Science in the Public Interest (CSPI), which involved 36 ... and looked at dietary information provided by four famous pizza ...
... in the Institute of Preventive Medicine in Copenhagen suggests ... dementia and Alzheimer's disease. Scientists, who found// that people ... two times less likely to develop dementia, said that ... in wine which reduce the occurrence of dementia. This ...
Cached Medicine News:Health News:Women on HRT should avoid alcohol 2Health News:Depressed women show signs of earlier onset of Perimenopause 2Health News:Pizza is bad for health. But, do you know how bad? 2
... Littmann Electronic Stethoscope Model 4100WS features amplification ... allowing you to reduce ambient noise by ... critical body sounds. Three frequency modes are ... other body sounds: Bell (20-200 Hz), Diaphragm ...
... the best EMR value for many medical ... Charting Plus™ relies heavily on a user-friendly ... improve documentation quality and increase productivity in ... specific to your medical specialty. Each program ...
... is a portable, battery-powered bone growth stimulator used ... device is worn for 30 minutes each day ... fusion site. The device uses a unique technology, ... energy signal that is very potent in its ...
... is a multi-site, implantable biventricular ... and two ventricular ports for ... (AF) who have undergone an ... have NYHA Class II or ...
Medicine Products: